| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 09/07/2005 | CN1665507A Therapeutic 1, 2, 3, 6-tetrahydropyrimidine-2-one compositions and methods therewith |
| 09/07/2005 | CN1665475A Merocyanine derivatives for cosmetic use |
| 09/07/2005 | CN1217946C Process for preparing pyrazolopyrimidinone derivatives for treatment of impotence |
| 09/07/2005 | CN1217932C Antibacterial agents |
| 09/07/2005 | CN1217711C Dry powder dispersing apparatus |
| 09/06/2005 | US6939967 Non-proteinogenic L-amino acids |
| 09/06/2005 | US6939882 Fungicides |
| 09/06/2005 | US6939872 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 09/01/2005 | WO2005080377A1 COMPOUND HAVING TGF-β INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME |
| 09/01/2005 | WO2005080361A1 Histamine-3 receptor modulators |
| 09/01/2005 | WO2005080352A2 Quinazoline derivatives and therapeutic use thereof |
| 09/01/2005 | WO2005080351A1 The preparation and application of a n4-oxycarbonylcytosine derivatives |
| 09/01/2005 | WO2005080350A1 Pyrimidine derivatives as cannabinoid receptor modulators |
| 09/01/2005 | WO2005080349A1 Pyrimidine derivatives |
| 09/01/2005 | WO2005079801A1 Pyrimidine compounds as purine receptor antagonist |
| 09/01/2005 | WO2005079800A1 Pyrimidine compounds as purine receptor antagonist |
| 09/01/2005 | WO2005079798A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides |
| 09/01/2005 | WO2004085358A8 Process for producing tetraalkoxypropane and derivative thereof |
| 09/01/2005 | WO2003101941A3 Alpha acyloxyacetamides for kallikrein and urokinase inhibition |
| 09/01/2005 | US20050192316 Aryl aniline beta2 adrenergic receptor agonists |
| 09/01/2005 | US20050192306 Pyrimidine derivatives as selective inhibitors of COX-2 |
| 09/01/2005 | US20050192305 4-[[4-[(2,6-dichloro-phenyl)methyl]-6-[[2-(1-pyrrolidinyl)ethyl]amino]-2-pyrimidinyl]amino]benzonitrile; 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzamide, N1-oxide; viricides; from intermediates; treating AIDS |
| 09/01/2005 | US20050192304 Rho-kinase inhibitors |
| 09/01/2005 | US20050192301 Use to prepare antiproliferative anticancer agents such as 2-(p-(4-methylpiperazino)-3-methylphenylamino)-4-(2-formamidocyclopentylamino)-5-fluoro-pyrimidine |
| 09/01/2005 | US20050192297 melanocortin-4 receptor (MC4-R) agonists; antidiabetic agents; non-insulin dependent diabetes; obesity |
| 09/01/2005 | US20050192284 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use |
| 09/01/2005 | US20050192280 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| 09/01/2005 | US20050191367 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 09/01/2005 | CA2557433A1 Quinazoline derivatives and therapeutic use thereof |
| 09/01/2005 | CA2557158A1 Prophylactic antimigraine agents |
| 09/01/2005 | CA2556480A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides |
| 09/01/2005 | CA2555071A1 Histamine-3 receptor modulators |
| 09/01/2005 | CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production |
| 08/31/2005 | EP1568695A1 3,4-Dihydroquinazoline derivatives as T-type calcium channel blockers and method of preparing the same |
| 08/31/2005 | EP1568690A1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |
| 08/31/2005 | EP1568367A1 Compounds effecting glucokinase |
| 08/31/2005 | EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 08/31/2005 | EP1567506A2 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 08/31/2005 | EP1567505A2 Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
| 08/31/2005 | EP1567498A2 Mandelic acid derivatives |
| 08/31/2005 | EP1567494A1 Methods for preparing phenylalkyne derivatives |
| 08/31/2005 | EP1567010A1 Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides |
| 08/31/2005 | EP1417207B1 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones |
| 08/31/2005 | EP1289963B1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 08/31/2005 | EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 08/31/2005 | EP1117424B1 Null igf for the treatment of cancer |
| 08/31/2005 | EP1003497B1 Il-8 receptor antagonists |
| 08/31/2005 | CN1662514A Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 08/31/2005 | CN1662236A Inhibitors of histone deacetylase |
| 08/31/2005 | CN1660820A 3, 4-dihydroquinazoline derivatives as t-type calcium channel blockers and method of preparing the same |
| 08/31/2005 | CN1660819A Ramification of N-carbethoxy cytosine and preparation method and application |
| 08/31/2005 | CN1660815A Cyclic amine derivatives and their use as drugs |
| 08/31/2005 | CN1660798A Processes for preparing aminophenylsulfonylureas, and intermediates therefor |
| 08/31/2005 | CN1216947C Reactive dye compounds |
| 08/31/2005 | CN1216872C Quinazoline derivatives and pharmaceutical applications thereof |
| 08/31/2005 | CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 08/30/2005 | US6936719 pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents |
| 08/30/2005 | US6936620 Nitrogen compounds such as 5-(4-(Benzyloxy)benzyl)-5-methyl-2, 4,6(1H,3H,5H)-pyrimidinetrione, used as enzyme inhibitors, used as antiinflammatory agents |
| 08/30/2005 | US6936616 Pyrimidine matrix metalloproteinase inhibitors |
| 08/30/2005 | US6936610 Heterocyclic derivatives |
| 08/30/2005 | US6936607 2,4,6-Triaminopyrimidines for the treatment of depression and/or anxiety |
| 08/30/2005 | US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 08/30/2005 | US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 08/30/2005 | US6936186 Mesomorphic compound, polymeric mesomorphic compound, and electrolyte and secondary battery including same |
| 08/25/2005 | WO2005077918A1 Pth agonists |
| 08/25/2005 | WO2005077917A1 Amorphous salts of rosuvastatin |
| 08/25/2005 | WO2005077916A1 Salts of hmg-coa reductase inhibitors and use thereof |
| 08/25/2005 | WO2005077905A1 Fused-ring 4-oxopyrimidine derivative |
| 08/25/2005 | WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both |
| 08/25/2005 | WO2005076861A2 Compounds that inhibit hiv particle formation |
| 08/25/2005 | WO2005076854A2 Pyrimidinone compounds useful as kinase inhibitors |
| 08/25/2005 | US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction |
| 08/25/2005 | US20050187285 administering anticholesterol agents to inhibit the induction of major histocompatibilty complex (MHC class II) expression by gamma-inteferon (IFN- gamma); treatment of autoimmune diseases |
| 08/25/2005 | US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation |
| 08/25/2005 | US20050187235 Pyrimidine derivatives useful as selective COX-2 inhibitors |
| 08/25/2005 | US20050187234 Reference standard for characterization of rosuvastatin |
| 08/25/2005 | US20050187232 Controlling cell proliferation; side effect reduction ; anticancer agenst |
| 08/25/2005 | US20050187231 4-aminoquinazolines e.g. 4-(4-phenylbutylamino)quinazoline; antiproliferative agents; antitumor agents; hyperproliferative disorders, including tumors, such as breast, brain, and kidney tumors |
| 08/25/2005 | US20050187222 Therapy for impotency, erectile dysfuction; benign prostatic hyperplasia; hypotensive agents; congestive heart failure; vision defects; neurodegenerative disorders; incotinence; cognition activators |
| 08/25/2005 | US20050187217 Sodium channel modulators; pain relievers; treating epilepsy, neurodegenerative disorders, psychiatric disorders, arrhythmia, movement disorders, autoimmune diseases, and incontinence; fused ring 4-aminopyrimidines e.g. 4-amino-5,6,7,8-tetrahydroquinazolines |
| 08/25/2005 | US20050187194 fructose 1,6-bisphosphatase (FBPase) inhibitors for diabetic complications, hyperlipidemia, hypertension, arteriosclerosis, macroangiopathy; 2-amino-5-isobutyl-4-{2-[5-(N,N'-bis((S)-1-ethoxycarbonyl)ethyl)phosphonamido]furanyl}thiazole |
| 08/25/2005 | US20050186176 Compounds and compositions for delivering active agents |
| 08/25/2005 | CA2555291A1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 08/25/2005 | CA2555132A1 Compounds that inhibit hiv particle formation |
| 08/24/2005 | EP1565446A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 08/24/2005 | EP1216246B1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | CN1659239A Yellow anionic disazo dyes |
| 08/24/2005 | CN1659150A Quinazoline derivative and medicine |
| 08/24/2005 | CN1659149A Method for producing 4, 6-dichloro-5-fluoropyrimidine |
| 08/24/2005 | CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives |
| 08/24/2005 | CN1658871A Amide derivatives as GK activators |
| 08/24/2005 | CN1657523A Cyclic compounds |
| 08/24/2005 | CN1216036C Chiral alkamine ligand and its application in asymmetrical addition of terminal alkyne para imine |
| 08/23/2005 | US6933298 Matrix metalloproteinase inhibitor; osteoporosis, antiarthritic agents, rheumatic diseases |
| 08/18/2005 | WO2005075477A1 Antibacterial compounds |
| 08/18/2005 | WO2005075458A1 Pyrimidine derivatives as orexin receptors antagonists |
| 08/18/2005 | WO2005075440A1 2- (phenylamino) -pyrimidin-5-amides as cannabinoid 2 receptors modulators for the treatment of immune or inflammatory disorders |
| 08/18/2005 | WO2005075439A1 Quinazoline derivatives |
| 08/18/2005 | WO2005075438A1 Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases |